Longeveron (LGVN) Operating Leases (2021 - 2026)
Longeveron's (LGVN) quarterly Operating Leases came in at $60000.0 in Q1 2026, down 90.96% year-on-year from $664000.0 in Q1 2025, and down 64.5% quarter-over-quarter from $169000.0 in Q4 2025.
Longeveron (LGVN) Operating Leases (2021 - 2026) Analysis & Trends
Longeveron's Operating Leases history runs 6 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- On a quarterly basis, Operating Leases fell 90.96% year-over-year to $60000.0 in Q1 2026; TTM through Mar 2026 was $60000.0, a 90.96% decrease from a year earlier, with the FY2025 full-year figure at $169000.0, down 79.49% from the prior year.
- Operating Leases slipped to $60000.0 in Q1 2026 per LGVN's latest filing, from $169000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.6 million in Q4 2022 and bottomed at $60000.0 in Q1 2026.
- The 5-year median for Operating Leases is $1.1 million (2024), against an average of $1.1 million.
- Across the five-year window, Operating Leases increased 0.05% in 2024 and tumbled 90.96% in 2026, its largest moves.
- Year by year, Operating Leases stood at $2.6 million in 2022, then sank by 44.31% to $1.4 million in 2023, then slumped by 43.09% to $824000.0 in 2024, then slumped by 79.49% to $169000.0 in 2025, then plunged by 64.5% to $60000.0 in 2026.
- Per Business Quant, the three latest LGVN Operating Leases figures stand at $60000.0 (Q1 2026), $169000.0 (Q4 2025), and $336000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 501,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 824,000.00 |
| Sep 30, 2024 | 983,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.61 Mn |